Unity Biotechnology Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Unity Biotechnology has a total shareholder equity of $19.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $53.5M and $33.8M respectively.
Anahtar bilgiler
0%
Borç/özkaynak oranı
US$0
Borç
Faiz karşılama oranı | n/a |
Nakit | US$33.98m |
Eşitlik | US$19.75m |
Toplam yükümlülükler | US$33.77m |
Toplam varlıklar | US$53.52m |
Son finansal sağlık güncellemeleri
Will Unity Biotechnology (NASDAQ:UBX) Spend Its Cash Wisely?
Jul 12Here's Why We're A Bit Worried About Unity Biotechnology's (NASDAQ:UBX) Cash Burn Situation
Mar 05Companies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Risky
Nov 18Recent updates
Will Unity Biotechnology (NASDAQ:UBX) Spend Its Cash Wisely?
Jul 12Here's Why We're A Bit Worried About Unity Biotechnology's (NASDAQ:UBX) Cash Burn Situation
Mar 05Companies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Risky
Nov 18UNITY Biotechnology falls 7% on reverse stock split
Oct 19Unity Biotechnology cuts stock sales agreement in half to $25M
Aug 19Unity Biotechnology GAAP EPS of -$0.19 beats by $0.10, revenue of $0.24M
Aug 12A Look At Unity's UBX1325 Phase 1 Results
Jul 26Trade Alert: The Co-Founder Of Unity Biotechnology, Inc. (NASDAQ:UBX), Nathaniel David, Has Sold Some Shares Recently
Dec 22A Look Inside Unity Bio's Transition To An Ophthalmology Company
Nov 27Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: UBX's short term assets ($35.8M) exceed its short term liabilities ($8.8M).
Uzun Vadeli Yükümlülükler: UBX's short term assets ($35.8M) exceed its long term liabilities ($25.0M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: UBX is debt free.
Borcun Azaltılması: UBX had no debt 5 years ago.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: UBX has sufficient cash runway for more than a year based on its current free cash flow.
Tahmini Nakit Akışı: UBX has sufficient cash runway for 1.1 years if free cash flow continues to grow at historical rates of 10.8% each year.